Haisco Pharmaceutical Group Co., Ltd. Stock Price

SZSE:002653 Community·CN¥61.6b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

002653 Share Price Performance

CN¥0

-42.90 (-100.00%)

CN¥0

-42.90 (-100.00%)

CN¥0

Wed, 29 Apr 26

Share Pricen/a

002653 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with proven track record and pays a dividend.

1 Risk

2 Rewards

View Full Analysis

Haisco Pharmaceutical Group Co., Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.69
: 74.46%
: 15.17%
: 45.7%

View Full Analysis

About 002653

Founded: 2000
Employees: 5597
CEO: Xiu Lian Fan
WebsiteView website: www.haisco.com

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.